Cannabis Insights
July 22, 2018
By Mary Amato, CPA, Partner, CohnReznick It is no secret that the Internal Revenue Service (IRS) is aggressively auditing cannabis businesses. The focus is on more […]
July 15, 2018
Despite federal prohibition of cannabis, the number of U.S. financial institutions serving the industry increased more than 29% in 18 months. Most institutions are state-chartered banks […]
July 8, 2018
Despite the majority of states allowing medical cannabis use, cannabis leads drug-related prosecutions in the U.S by a significant margin. Over 650,000 people were arrested for […]
July 8, 2018
Historic Massachusetts farm cultivates medical cannabis with a social conscience By Michael Harlow, CPA, Partner Beginning decades ago, George and Joanne Patton, son and daughter-in-law of […]
July 8, 2018
By J.J. McCoy, Senior Managing Editor for New Frontier Data New research from New Frontier Data finds that cannabis arrests account for 41.6% of all drug-related […]
July 1, 2018
The FDA last week approved UK-based GW Pharmaceuticals’ Epidiolex, a “pure plant-derived CBD” extract shown to drastically reduce seizures in children with epileptic syndromes. Marking the […]
June 24, 2018
More than a dozen states are expected pass new cannabis legalization measures before 2025. Of them, four are expected to open medical markets, while nine may […]
June 24, 2018
By J.J. McCoy, Senior Managing Editor for New Frontier Data Judging by a flurry of anxious headlines this month, the U.S. Congress (with President Trump’s “probable” […]
June 19, 2018
By Yona Torres, Editor, New Frontier Data As exiting opportunities arise from the Canadian cannabis market, investors should be aware of five key risks and exposures […]